|
🐜
|
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk: Insights From the FOURIER Trial
20 auth.
M. O’Donoghue,
S. Fazio,
R. Giugliano,
Erik S. G. Stroes,
Estella Kanevsky,
I. Gouni-Berthold,
K. Im,
Armando Lira Pineda,
S. Wasserman,
R. Češka,
...
M. Ezhov,
J. Jukema,
Henrik K. Jensen,
S. Lale Tokgözoğlu,
F. Mach,
K. Huber,
P. S. Sever,
A. Keech,
T. Pedersen,
M. Sabatine
|
9 |
2019 |
9
🐜
|
|
🐜
|
Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia
16 auth.
R. P. Surendran,
M. Visser,
S. Heemelaar,
Jian Wang,
Jorge Peter,
J. Defesche,
J. Kuivenhoven,
M. Hosseini,
M. Hosseini,
Miklós Péterfy,
...
Miklós Péterfy,
J. Kastelein,
C. T. Johansen,
Robert A. Hegele,
Erik S. G. Stroes,
G. Dallinga-Thie
|
7 |
2012 |
7
🐜
|
|
🐢
|
Prevention and epidemiology
12 auth.
M. Visser,
Gilbert Wagener,
Brenda F Baker,
Richard S. Geary,
Joanne M Donovan,
U. Beuers,
...
A. Nederveen,
Joanne Verheij,
M. Trip,
D. Basart,
John P. Kastelein,
Erik S. G. Stroes
|
7 |
2011 |
7
🐢
|
|
🐜
|
A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease.
13 auth.
G. Hovingh,
A. Brownlie,
R. Bisoendial,
M. Dubé,
J. Levels,
W. Petersen,
R. Dullaart,
Erik S. G. Stroes,
A. Zwinderman,
E. de Groot,
...
Michael R. Hayden,
J. Kuivenhoven,
J. Kastelein
|
7 |
2004 |
7
🐜
|
|
🐜
|
Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease Published, JLR Papers in Press, September 22, 2007.
10 auth.
Sander I van Leuven,
R. Hezemans,
J. H. M. Levels,
S. Snoek,
Pieter C. Stokkers,
G. Hovingh,
...
J. Kastelein,
Erik S. G. Stroes,
E. de Groot,
Daan W. Hommes
|
6 |
2007 |
6
🐜
|
|
🐜
|
Serum Levels of Mannose-Binding Lectin and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women
10 auth.
T. Keller,
S. V. Leuven,
M. C. Meuwese,
N. Wareham,
R. Luben,
Erik S. G. Stroes,
...
C. E. Hack,
M. Levi,
K. Khaw,
S. Boekholdt
|
6 |
2006 |
6
🐜
|
|
🐢
|
Carriers of lecithin cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging [corrected].
11 auth.
R. Duivenvoorden,
A. Holleboom,
B. van den Bogaard,
A. Nederveen,
E. de Groot,
B. Hutten,
...
A. Schimmel,
G. Hovingh,
J. Kastelein,
J. Kuivenhoven,
Erik S. G. Stroes
|
5 |
2011 |
5
🐢
|
|
🐢
|
Dilemmas in treatment of women with familial hypercholesterolaemia during pregnancy.
7 auth.
D. Kusters,
S. Homsma,
B. Hutten,
Marcel Th. B. Twickler,
Hans J. Avis,
A. PostvanderJ.,
...
Erik S. G. Stroes
|
5 |
2010 |
5
🐢
|
|
🐜
|
C-Reactive Protein, Fatal and Nonfatal Coronary Artery Disease, Stroke, and Peripheral Artery Disease in the Prospective EPIC-Norfolk Cohort Study
7 auth.
Diederik F Van Wijk,
S. Boekholdt,
N. Wareham,
S. Ahmadi-Abhari,
J. Kastelein,
Erik S. G. Stroes,
...
K. Khaw
|
5 |
2013 |
5
🐜
|
|
🐢
|
High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C
9 auth.
A. Bochem,
A. Holleboom,
J. Romijn,
M. Hoekstra,
G. Dallinga-Thie,
M. Motazacker,
...
G. Hovingh,
J. Kuivenhoven,
Erik S. G. Stroes
|
5 |
2013 |
5
🐢
|
